State of the ART: Applying Up-to-Date Safety and Tolerability Data to Individualize HIV Care

In this comprehensive educational program expert faculty discuss the latest updates on ART safety and tolerability issues focusing on unique populations such as pregnant women aging patients populations with cardiometabolic toxicities and transgender persons.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from Janssen Therapeutics, Division of Janssen Products, LP and ViiV Healthcare.

Janssen Therapeutics, Division of Janssen Products, LP

ViiV Healthcare